Mylan New Zealand - Latest News [Page 1]
Mylan Initiates Recall of EpiPen® Auto-Injector in NZ
Wednesday, 22 March 2017, 1:42 pm | Mylan New Zealand
Mylan New Zealand Ltd, following consultation with Medsafe, Ministry of Health, New Zealand is recalling the following batches of EpiPen® 300 microgram (µg) Adrenaline Auto-Injectors due to the potential that these devices may contain a defective part ... More >>
Recall: PACIFIC ATENOLOL (Atenolol) 50mg, 100mg
Thursday, 27 May 2010, 10:36 am | Mylan New Zealand
Mylan New Zealand Limited, following consultation with Medsafe, Ministry of Health, is recalling all Pacific Atenolol 50mg and 100mg tablets, which are manufactured by IPCA Laboratories Limited and marketed by Mylan New Zealand. More >>
Medicine recall: Respigen 100 microgram aerosol
Tuesday, 30 March 2010, 1:18 pm | Mylan New Zealand
Mylan New Zealand, in consultation with Medsafe, is recalling one batch of Respigen (salbutamol) 100 microgram Inhalation aerosol (batch number 9F282A) which is manufactured by Pharmaserve NW in the UK and marketed by Mylan New Zealand. The affected batch ... More >>
Financial Relief to Those with Alzheimer’s
Monday, 27 July 2009, 1:24 pm | Mylan New Zealand
Mylan New Zealand today announced that the first generic prescription medicine for those with Alzheimer’s disease, the most common cause of dementia, is now available in New Zealand. The availability of a generic version of donepezil provides a more ... More >>